Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2021-06-16 M&A Activity
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Letter to Shareholders re takeover offer 1 page 133
M&A Activity Classification · 95% confidence The document is a letter from the Chairman of Adherium Limited to shareholders regarding an unsolicited off-market takeover offer by Respiri Limited. It discusses the offer terms, the board's recommendation to reject the offer, and mentions that a Target's Statement will be mailed soon. This is a communication related to a merger or acquisition activity, specifically a takeover bid. The document is not a full merger proxy statement or tender offer filing but an announcement related to M&A activity. Therefore, the appropriate classification is 'M&A Activity' (TAR). The document length is short and does not contain financial statements or detailed financial analysis, so it is not an Annual Report or similar. Confidence is high due to clear references to takeover offer and board recommendation.
2021-06-16 English
RSH: Notice of Dispatch 101 pages 2.1MB
Merger & Acquisition Classification · 95% confidence The document is a detailed Bidder's Statement related to an off-market takeover bid by Respiri Limited for all ordinary shares in Adherium Limited. It references the Corporations Act 2001, includes legal disclaimers, offer terms, and instructions for shareholders. The content is focused on the takeover bid process and the offer details, which aligns with merger and acquisition activity filings. It is not an announcement of a report, nor a financial report itself, but a formal document related to a takeover bid. Therefore, the appropriate classification is Merger & Acquisition (MA). The document length and detail support this classification with high confidence.
2021-06-14 English
Adherium responds to Respiri announcement 2 pages 125.4KB
M&A Activity Classification · 95% confidence The document is an announcement from Adherium Limited responding to a takeover proposal by Respiri Ltd. It references a Directors' Statement and a Bidder's Statement related to the takeover. The content focuses on the company's position regarding the takeover offer and the recommendation to shareholders to reject the offer. There is no detailed financial data, quarterly or annual report content, or audit information. The document is a communication related to merger and acquisition activity, specifically addressing the takeover bid and related statements. Therefore, the appropriate classification is 'M&A Activity' (TAR). The document length is 3035 characters, which is consistent with an announcement rather than a full report.
2021-06-06 English
RSH:RPM CPT Reimbursement&response to statements made by ADR 4 pages 146.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 3 June 2021 from Respiri Limited. It discusses the company's progress towards securing reimbursement for its medical device under the US RPM CPT code system, addresses statements made by a competitor, and provides detailed information about the device, clinical studies, and regulatory clearances. The document is a public announcement of business developments and clarifications rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements, management discussion of financial results, or detailed investor presentation slides. It is not a report publication announcement since it is substantive and not merely stating a report is available. The content fits best as a general regulatory announcement about company progress and market communication, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2021-06-02 English
Adherium submits next gen sensor for US FDA clearance 2 pages 140.3KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing the submission of a US FDA 510(k) application for a new medical device by Adherium Limited. It discusses the product features, market potential, and includes quotes from company executives and researchers. There are no financial statements, regulatory certifications, voting results, or detailed financial data. The document is an announcement of a regulatory submission and product development, not a financial report or detailed regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is also not a management or board change announcement, nor a legal proceeding or merger activity. The content is best classified as a general regulatory announcement about a product submission to the FDA, which fits under Regulatory Filings (RNS) as a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-05-31 English
RSH: 1st Supplementary Bidder's Statement(marked up replac 107 pages 2.8MB
M&A Activity Classification · 100% confidence The document is titled 'First Supplementary Bidder’s Statement' and relates to an off-market takeover bid for Adherium Limited by Respiri Limited. It references sections of the Corporations Act 2001 (Cth) and ASIC Class Orders, indicating it is a formal takeover bid document. The text includes details about the replacement bidder's statement, timetable for the offer, and legal disclaimers typical of takeover bid communications. This type of document is specifically related to merger and acquisition activity, as it involves a takeover bid and supplementary bidder's statement. Therefore, the document fits the category of Merger & Acquisition filings rather than general regulatory filings or announcements.
2021-05-26 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.